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Leukocytes, such as lymphocytes and macrophages, predominantly express delayed rectiﬁer K+ channels (Kv1.3), and the channels
play crucial roles in the activation and proliferation of the cells. Since lymphocytes are activated in patients with end-stage renal
disease (ESRD), the channels expressed in those cells would contribute to the progression of renal ﬁbrosis in advanced-stage
chronic renal failure (CRF). In the present study, using a rat model with advanced CRF that underwent 5/6 nephrectomy followed
by a 14-week recovery period, we examined the histopathological features of the kidneys and the leukocyte expression of Kv1.3-
channels and cell cycle markers. Age-matched sham-operated rats were used as controls. In the cortical interstitium of advanced
CRF rat kidneys, leukocytes proliferated in situ and overexpressed Kv1.3 channel protein in their cytoplasm. Treatment with
margatoxin, a selective Kv1.3-channel inhibitor, signiﬁcantly suppressed the number of leukocytes and the progression of renal
ﬁbrosis with a signiﬁcant decrease in the cortical cell cycle marker expression. This study demonstrated for the ﬁrst time that
the number of leukocytes was dramatically increased in rat kidneys with advanced CRF. The overexpression of Kv1.3 channels in
the leukocytes was thought to contribute to the progression of renal ﬁbrosis by stimulating cell cycling and promoting cellular
proliferation.
1.Introduction
Chronic renal failure (CRF) progresses relentlessly to end-
stage renal disease (ESRD). In patients with advanced CRF,
the disease tends to progress faster than in those with mild
to moderate CRF [1, 2]. Although several factors, such as
advanced age, hypertension, dehydration, and the use of
drugs,areknowntoaﬀecttherateofprogression[3–5],itcan
spontaneously accelerate despite the absence of such aggra-
vating factors [1]. These ﬁndings indicate the involvement of
an additional mechanism that promotes the progression of
CRF in the advanced-stage. The histopathology of kidneys
in CRF is characterized by tubulointerstitial ﬁbrosis in both
humans [6, 7] and experimental animal models [8–10].
In the development of renal ﬁbrosis, previous studies have
revealed the initial involvement of inﬂammatory leukocytes,
such as lymphocytes, macrophages, and mast cells [11, 12].
However, we know little about their later involvement in the
progression of renal ﬁbrosis in the advanced-stage, partly
because of the high mortality rate of the experimental
animals [11]. Lymphocytes and macrophages predominantly
express delayed rectiﬁer K+-channels (Kv1.3) in their plasma
membranes, and the channels play crucial roles in the
activation and proliferation of the cells [13–16]. Since
lymphocytes are activated [17] and serum cytokine levels
are much elevated in patients with ESRD [18, 19], the
channels expressed in the leukocytes would contribute to the
progression of renal ﬁbrosis in advanced CRF. To elucidate2 International Journal of Nephrology
Table 1: Primers used for quantitative real-time reverse transcriptase-PCR.
Gene Primer Product length (bp)
CD3 Forward: CAAAGAAACTAACATGGAGCAGGG 120
Reverse: CTTTTTGCTGGGCCATGGT
ED-1 Forward: TGTACCTGACCCAGGGTGGAA 92
Reverse: GAATCCAAAGGTAAGCTGTCCGTAA
KCNA3 Forward: GCTCTCCCGCCATTCTAAG 141
Reverse: TCGTCTGCCTCAGCAAAGT
Cdk4 Forward: CAATGTTGTACGGCTGATGG 120
Reverse: GGAGGTGCTTTGTCCAGGTA
p21 Forward: AGCAGTTGAGCCGCGATT 124
Reverse: CGAACACGCTCCCAGACG
GAPDH Forward: GGCACAGTCAAGGCTGAGAATG 143
Reverse: ATGGTGGTGAAGACGCCAGTA
this, using a rat model with advanced CRF, we examined the
histopathologicalfeaturesofthekidneysandtheinvolvement
of Kv1.3 channel and cell cycle marker expression in the
pathogenesis. Here, we show for the ﬁrst time that the
number of leukocytes dramatically increased in rat kidneys
with advanced CRF. We also show that the overexpression
of Kv1.3 channels in the leukocytes contributed to the
progression of renal ﬁbrosis by stimulating cell cycling and
promoting cellular proliferation.
2.MaterialsandMethods
2.1. Animal Preparation. Rats with 5/6 nephrectomy with
r e c o v e r yp e r i o d sa sl o n ga s1 4w e e k sw e r eu s e da st h em o d e l
of advanced CRF in the present study. Subtotal nephrectomy
was performed in male Sprague-Dawley rats weighing 150–
180g (Japan SLC Inc., Shizuoka, Japan) as described in our
previous study [20]. Brieﬂy, the upper 1/3 and lower 1/3 of
the right kidney were ligated to induce infarction. One week
later, the left kidney was removed. During the subsequent
14 weeks, rats had free access to standard rat chow and
water ad libitum and were maintained in a humidity- and
temperature-controlled room on a 12-hour light-dark cycle.
Age-matched sham operated rats were used as controls.
For the treatment with Kv1.3 channel inhibitor, margatoxin
(Peptide Institute, Osaka, Japan) was dissolved in distilled
water to prepare a concentration of 100nM. Twelve weeks
after subtotal nephrectomy, CRF rats were intraperitoneally
injected with 100nM/mL margatoxin daily for two weeks. At
the end of the 14-week recovery period, the rats were deeply
anaesthetized with isoﬂurane and then killed by cervical
dislocation. Trunk blood was withdrawn for the measure-
ments of serum creatinine, urea nitrogen, and potassium
levels. Kidneys were removed for histological examination
and RNA extraction. All experimental protocols described in
the present study were approved by the Ethics Review Com-
mittee for Animal Experimentation of Tohoku University.
2.2. Immunohistochemistry. Three-micrometer paraﬃns e c -
tions of 4% paraformaldehyde-ﬁxed kidneys were placed in
citrate-buﬀeredsolution (pH6.0)andthenboiled for30min
for antigen retrieval. Endogenous peroxidase was blocked
with 3% hydrogen peroxide, and nonspeciﬁc binding was
blocked with 10% BSA. Primary antibodies were as follows:
rabbit anti-Ki-67 (1:100; Lab Vision Co., Fremont, CA,
USA), anti-Kv1.3 (1:100; Alomone Labs Ltd., Jerusalem,
Israel), and mouse anticollagen type III (1:100; Abnova,
Taipei City, Taiwan). Diaminobenzidine substrate (Sigma
Chemical Co., St. Louis, MO, USA) was used for the color
reaction. For Kv1.3 and collagen III staining, sections were
counterstained with hematoxylin. Secondary antibody alone
was consistently negative on all sections.
2.3. Real-Time RT-PCR. Total RNAs from freshly isolated
renal cortex were extracted using the RNeasy mini kit (Qia-
gen, Hilden, Germany). First-stand cDNA was synthesized
from 2μgo ft o t a lR N Ao fe a c ht i s s u ei n2 0μLo fr e a c t i o n
mixture using the SuperScript VILO ﬁrst-strand synthesis
kit (Invitrogen, Carlsbad, CA, USA). The quantitative RT-
PCRwascarriedoutusingtheAppliedBiosystems7500Real-
Time PCR System (Life Technologies Inc., Gaithersburg,
MD, USA) with SYBR Premix Ex Taq II (Takara Bio, Kyoto,
Japan). The quantity of RNA samples was normalized by the
expression level of GAPDH. The sequences of the primers
used are listed in Table 1.
2.4. Other Measurements and Statistical Analyses. Serum cre-
atinine, urea nitrogen, and potassium levels were measured
using a chemical autoanalyzer (DRI-CHEM 3500V; Fuji,
Tokyo, Japan). Data were analyzed using Microsoft Excel
(Microsoft Co., Redmond, WA, USA) and reported as means
± SEM. Statistical signiﬁcance was assessed by a two-way
ANOVA followed by Dunnett’s or Student’s t-test. A value
of P<0.05 was considered signiﬁcant.
3. Results
3.1. In Situ Proliferation of Inﬂammatory Leukocytes in
Rat Kidneys with Advanced CRF. The marked elevation of
serum creatinine (4.45 ± 1.16 versus sham operated 0.33 ±International Journal of Nephrology 3
0.03mg/dL, n = 6, P<0.05) and urea nitrogen (130 ± 8.95
versus sham operated 15.5 ± 1.39mg/dL, n = 6, P<0.05)
levels in nephrectomized rats indicated advanced CRF with
severe uremia [11]. The rats presented hyperkalemia (6.9 ±
0.5 versus sham operated 4.3 ± 0.05mEq/L, n = 6, P<0.05)
as a result of deteriorated renal function. Sections of kidneys
from sham operated rats showed normal tubulointerstitium
of the cortex (Figures 1A(a) and 1A(c)). In CRF rat kidneys,
as previously demonstrated [8, 10, 12], diﬀuse ﬁbrosis was
noted in the medullary and papillary interstitium (data not
shown). In the cortical interstitium, in addition to ﬁbrosis, a
substantial number of small, round cells were noted among
spindle-shaped ﬁbroblasts (Figures 1A(b) and 1A(d)). Since
the mRNA expression of CD3 and ED-1, surface markers for
T-lymphocytes and macrophages, was markedly elevated in
the cortex isolated from CRF rat kidneys (Figure 1(B)), those
round cells were considered to be inﬂammatory leukocytes,
such as T-lymphocytes and macrophages.
In sham operated rat kidneys, immunohistochemistry
for Ki-67, a marker of cellular proliferation, was only weakly
positive in some proximal tubular cells (Figure 1C(a)).
In CRF rat kidneys, however, the immunohistochemistry
demonstrated a number of positively stained small, round
cells within the cortical interstitium (Figure 1C(b)), indicat-
ing that inﬂammatory leukocytes were proliferating in the
kidneys of advanced CRF.
3.2. Overexpression of Kv1.3-Channels in the Leukocytes
and Expression of Cell Cycle Markers. Since lymphocytes
and macrophages express Kv1.3 channels in their plasma
membranes [13, 14], and since the channels trigger the
calcium inﬂux necessary for cellular proliferation [15, 16],
we examined the expression of the channel in leukocytes
of the rat kidneys (Figure 2(A)). The mRNA expression of
KCNA3 gene, which encodes Kv1.3, was markedly elevated
in the cortex isolated from CRF rat kidneys (Figure 2A(a)).
In sham operated rats, as previously demonstrated [21],
immunohistochemistry for Kv1.3 showed a weak staining in
the cytoplasm of some proximal tubular cells (Figure 2A(b),
arrows), but not in small round cells in the cortical intersti-
tium (arrow heads). In CRF rats, however, the cytoplasmic
expression of Kv1.3 was increased speciﬁcally in small round
cells proliferating in the cortical interstitium (Figure 2A(c),
arrow heads), indicating the overexpression of the channels
in the leukocytes.
Since overexpression of Kv1.3 channels is known to aﬀect
the cell cycle progression in various types of cancer cells
[22, 23], we then examined the expression of cell cycle
markers, such as cyclin-dependent kinase 4 (Cdk4) and its
inhibitor, p21 (Figure 2(B)). In CRF rat kidneys, the cortical
expression of Cdk4 mRNA was signiﬁcantly increased, but
that of p21 mRNA was signiﬁcantly decreased compared to
sham operated rat kidneys.
3.3. Eﬀects of a Selective Kv1.3-Channel Inhibitor on Renal
Fibrosis and Cell Cycle Marker Expression. To obtain the
direct evidence that the overexpression of Kv1.3 channels
actually contributes to the proliferation of leukocytes and to
the progression of renal ﬁbrosis, we ﬁnally examined CRF
rat kidneys after treating with margatoxin, a selective Kv1.3
channel inhibitor [22, 24]. In CRF rat kidneys with marga-
toxin treatment, proximal tubules were partially preserved,
although they were atrophic (Figure 3A(a)). Compared to
CRF rat kidneys without treatment (Figures 1A(b) and
1A(d)), the size of the cortical interstitium was smaller
(Figure 3A(a)), and the number of inﬁltrating leukocytes
w a sm u c hl e s s( Figure 3A(b)). Immunohistochemistry for
collagen III, a marker of ﬁbrosis, demonstrated less staining
in the cortical interstitium of margatoxin-treated CRF rat
kidneys (Figure 3B(b) versus 3B(a)), indicating that marga-
toxin reduced the progression of renal ﬁbrosis. The cortical
expression of Cdk4 mRNA was signiﬁcantly decreased after
margatoxin treatment (Figure 3(C), left), and that of p21
mRNAwassigniﬁcantlyincreasedafterthetreatment(right).
These results suggested that the overexpression of Kv1.3
channels in leukocytes was strongly associated with the
promotion of cell cycling, and thus with the progression of
renal ﬁbrosis.
4. Discussion
In the development of tubulointerstitial ﬁbrosis in CRF rat
kidneys, inﬂammatory leukocytes are initially recruited from
the bone marrow and inﬁltrate into the renal interstitium
to trigger the proliferation of ﬁbroblasts [25]. Then, with
the progression of uremia, the number of such leukocytes
is considered to decrease due to the decrease in circulating
lymphocyte counts [26]. In advanced CRF, however, the
present study demonstrated that the numbers of leukocytes
in the cortical interstitium were dramatically increased by in
situ proliferation, showing pathological features similar to
those of acute glomerulonephritis [27]. Since the cytokines
produced by leukocytes stimulate the activity of ﬁbroblasts
to produce collagen [25],the increased number of leukocytes
in the interstitium would promote the progression of renal
ﬁbrosis and thus contribute to the rapid deterioration of
renal function in advanced CRF.
Previous studies have demonstrated the overexpression
of Kv1.3-channnels in cells under various pathologic condi-
tions, including cancer [28, 29] and ischemic heart disease
[30]. Concerning the mechanisms involved in such overex-
pressionofthechannels,stimulationbytransforminggrowth
factor-β (TGF-β) was one of the most likely candidates
demonstrated in macrophages [31]. Since uremic toxins,
such as indoxyl sulfate, upregulate the expression of TGF-
β [32], they might be responsible for the overexpression of
the channels in leukocytes in advanced CRF. By generating a
drivingforceforthecalciuminﬂux,Kv1.3channelsexpressed
in lymphocytes trigger the calcium signaling necessary for
cellular proliferation [15, 16]. From our results, as demon-
strated in cancer cells [33], the membrane hyperpolarization
induced by the overexpression of the channels would also
promote the proliferation of leukocytes by directly stimulat-
ing cell cycle progression.
In addition to their role in cellular proliferation, Kv1.3
channels expressed in lymphocytes and macrophages trigger4 International Journal of Nephrology
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Figure 1: Histological features of sham operated (sham) and advanced CRF rat kidneys. (A) Hematoxylin and eosin staining (H&E) in sham
operated (sham) and advanced CRF rat kidneys. (a) and (b) Low-power views of cortex. Magniﬁcation, ×20. (c) and (d) High-power views
of cortical interstitium. Magniﬁcation, ×60. (B) The mRNA abundance of CD3 (left) and ED-1 (right) in the renal cortex of sham operated
and advanced CRF (CRF) rat kidneys. #P<0.05 versus sham operated rats. Values are means ± SEM (n = 6). Diﬀerences were analyzed
by ANOVA followed by Dunnett’s or Student’s t-test. (C) Immunohistochemistry using antibody for Ki-67 (brown) in sham operated and
advanced CRF rat kidneys. (a) and (b) High-power views of cortical interstitium. Magniﬁcation, ×60.International Journal of Nephrology 5
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Figure 2: Kv1.3 and cell cycle marker expression in sham operated (sham) and advanced CRF rat kidneys. (A) Kv1.3 expression. (a) KCNA3
mRNA abundance in the renal cortex of sham operated (sham) and advanced CRF (CRF) rat kidneys. (b) and (c) Immunohistochemistry
usingantibodyforKv1.3(brown)inshamoperatedandadvancedCRFratkidneys.High-powerviewsofcorticalinterstitium.Magniﬁcation,
×60. (B) Cell cycle marker expression. The mRNA abundance of cyclin-dependent kinase 4 (Cdk4) (left) and p21 (right) in the renal cortex
of sham operated and advanced CRF rat kidneys. #P<0.05 versus sham operated rats. Values are means ± SEM (n = 6). Diﬀerences were
analyzed by ANOVA followed by Dunnett’s or Student’s t-test.6 International Journal of Nephrology
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Figure 3: Collagen III and cell cycle marker expression in advanced CRF rat kidneys after margatoxin (MgTX) treatment. (A) Hematoxylin
and eosin staining (H&E) in advanced CRF rat kidneys after margatoxin (MgTX) treatment. (a) A low-power view of cortex. Magniﬁcation,
×20.(b)Ahigh-powerviewofcorticalinterstitium.Magniﬁcation, ×60.(B)ImmunohistochemistryusingantibodyforcollagenIII(brown)
in advanced CRF rat kidneys with and without MgTX treatment. (a) and (b) Low-power views of cortex. Magniﬁcation, ×20. (C) Cell cycle
marker expression. The mRNA abundance of Cdk4 (left) and p21 (right) in the renal cortex of advanced CRF rat kidneys with and without
MgTX treatment.
∗P < 0.05 versus advanced CRF rats without treatment. Values are means ± SEM (n = 6). Diﬀerences were analyzed by
ANOVA followed by Dunnett’s or Student’s t-test.International Journal of Nephrology 7
the cytokine production from those cells [14–16]. Therefore,
the overexpression of the channels in leukocytes would have
multipliable eﬀects on the progression of renal ﬁbrosis. A
previous study has demonstrated the therapeutic eﬃcacy of
blocking the intermediate-conductance Ca2+-activated K+-
channels (Kca3.1) for renal ﬁbrosis, since ﬁbroblasts over-
expressed the channels under the pathologic condition [34].
From our results, targeting the Kv1.3 channels overexpressed
in leukocytes would also be useful for the treatment of
renal ﬁbrosis in advanced CRF. In addition to the selective
blockers for the channel that have previously been developed
[35], we have recently demonstrated the inhibitory eﬀects
of nonsteroidal anti-inﬂammatory drugs (NSAIDs), such
as diclofenac sodium, salicylate, and indomethacin, on
Kv1.3 channels expressed in lymphocytes [36]. Concerning
such properties, these drugs would potentially be useful as
antiﬁbrotic agents in patients with advanced CRF.
In summary, this study demonstrated for the ﬁrst time
that the number of leukocytes was dramatically increased in
rat kidneys with advanced CRF. The overexpression of Kv1.3
channels in the leukocytes was thought to contribute to the
progression of renal ﬁbrosis by stimulating cell cycling and
promoting cellular proliferation.
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